Li Jingjing, Li Renkai, Wu Xiaoping, Zheng Chengwen, Shiu Polly Ho-Ting, Rangsinth Panthakarn, Lee Simon Ming-Yuen, Leung George Pak-Heng
Department of Rehabilitation Sciences, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
Department of Pharmacology and Pharmacy, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Front Pharmacol. 2022 Jul 19;13:928817. doi: 10.3389/fphar.2022.928817. eCollection 2022.
Angiogenesis, the formation of new capillaries from pre-existing vascular networks, plays an important role in many physiological and pathological processes. The use of pro-angiogenic agents has been proposed as an attractive approach for promoting wound healing and treating vascular insufficiency-related problems, such as ischemic heart disease and stroke, which are the leading causes of death worldwide. Traditional herbal medicine has a long history; however, there is still a need for more in-depth studies and evidence-based confirmation from controlled and validated trials. Many and studies have reported that herbal medicines and their bioactive ingredients exert pro-angiogenic activity. The most frequently studied pro-angiogenic phytochemicals include ginsenosides from , astragalosides and calycosin from Radix Astragali, salvianolic acid B from , paeoniflorin from Radix Paeoniae, ilexsaponin A1 from , ferulic acid from , and puerarin from Radix puerariae. This review summarizes the progress in research on these phytochemicals, particularly those related to pro-angiogenic mechanisms and applications in ischemic diseases, tissue repair, and wound healing. In addition, an outline of their limitations and challenges during drug development is presented.
血管生成是指从已有的血管网络形成新的毛细血管,在许多生理和病理过程中发挥着重要作用。使用促血管生成剂已被提议作为促进伤口愈合和治疗与血管功能不全相关问题(如缺血性心脏病和中风,它们是全球主要死因)的一种有吸引力的方法。传统草药有着悠久的历史;然而,仍需要进行更深入的研究以及来自对照和验证试验的循证确认。许多研究报告称,草药及其生物活性成分具有促血管生成活性。研究最频繁的促血管生成植物化学物质包括人参中的人参皂苷、黄芪中的黄芪皂苷和毛蕊异黄酮、丹参中的丹酚酸B、芍药中的芍药苷、冬青中的冬青皂苷A1、阿魏中的阿魏酸以及葛根中的葛根素。本综述总结了这些植物化学物质的研究进展,特别是与促血管生成机制以及在缺血性疾病、组织修复和伤口愈合中的应用相关的进展。此外,还概述了它们在药物开发过程中的局限性和挑战。